NCT00604760
Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2007
Completion: Not specified